Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 28
Filter
1.
Zhonghua Yu Fang Yi Xue Za Zhi ; 55(9): 1129-1132, 2021 Sep 06.
Article in Chinese | MEDLINE | ID: mdl-34619932

ABSTRACT

In 2019, the rate of primary tooth caries rate among 1 598 preschool children in Shinan District and Shibei District of Qingdao was 59.4%. The multivariate logistic regression model showed that compared with children ≤ 2 years old with history of iron deficiency anemia (IDA), suffering IDA, breastfeeding to 2 years old and no tooth melanin, children ≤ 2 years old without history of IDA, not suffering IDA, breastfeeding to less than 2 years old and heavy tooth melanin had a lower risk of primary tooth caries, with OR (95%CI) values about 0.328 (0.197-0.549), 0.354 (0.208-0.603), 0.636 (0.437-0.926) and 0.301 (0.143-0.635), respectively.


Subject(s)
Dental Caries , Child, Preschool , Dental Caries/epidemiology , Humans , Logistic Models , Prevalence , Tooth, Deciduous
2.
Zhonghua Wei Chang Wai Ke Za Zhi ; 24(5): 420-425, 2021 May 25.
Article in Chinese | MEDLINE | ID: mdl-34000771

ABSTRACT

Objective: To compare the efficacy between laparoscopic and open proximal gastrectomy with double-tract reconstruction for Siewert type II and III adenocarcinoma of the esophagogastric junction (AEG). Methods: A retrospective cohort study was conducted. Inclusion criteria: (1) 18 to 80 years old; (2) Siewert II and III AEG was confirmed by preoperative gastroscopy and biopsy, which could not be resected by endoscopy; patients undergoing radical proximal gastrectomy with double-tract reconstruction; (3) contrast-enhanced abdominal CT staging was cT1-2N0M0; (4) Eastern Cooperative Oncology Group (ECOG) physical status score <2 points, American Association of Anesthesiologists (ASA) grade 1 to 2; (5) patients agreed to perform proximal gastrectomy and signed an informed consent. Those who had undergone neoadjuvant radiochemotherapy, suffered from serious mental diseases and had incomplete data were excluded. According to the above criteria, clinical data of 84 consecutive patients with Siewert II and III AEG undergoing surgery at General Surgery Department of The Affiliated Tumor Hospital of Zhengzhou University from October 2010 to December 2018 were collected and analyzed. Of 84 patients, 61 underwent open proximal gastrectomy with double-tract reconstruction (OPG group), while 23 underwent laparoscopic proximal gastrectomy with double-tract reconstruction (LPG group). The perioperative complications and postoperative reflux esophagitis of two groups were compared. A P-value of <0.05 was considered to be statistically significant. Results: Among 84 cases, 74 were male and 10 were female. There were 43 cases of Siewert type II and 41 cases of Siewert type III. There were no significant differences in age, gender, body mass index, comorbidities, Siewert type, and tumor staging between the two groups (all P>0.05). As compared to the OPG group, the LPG group had longer operation duration [(223±21) minutes vs. (161±14) minutes, t=15.352, P<0.001], less intraoperative blood loss [195 (150, 215) ml vs. 208 (192, 230) ml, Z=2.143, P=0.032], and shorter time to flatus [(2.8±0.7) days vs. (3.3±0.9) days, t=2.477, P=0.015]. There were no significant differences in the number of harvested lymph nodes, time to the first meal and postoperative hospital stay between the two groups (all P>0.05). Postoperative complications developed in 2 cases (8.7%, 1 case each for anastomotic leakage and intestinal obstruction) in the LPG group and 5 cases (8.2%, 1 case each for anastomotic leakage, anastomotic bleeding, and anastomotic stenosis, 2 cases of incision infection) in the OPG group (χ(2)=5.603, P=0.231). The median follow-up was 41.2 (12.8-110.5) months. One patient (1.6%,1/61) had obvious reflux symptoms in the OPG group, compared with none in the LPG group (χ(2)=0.644, P=0.422). Esophagitis occurred in 1 case (4.8%, 1/21) in LPG group, compared with 4 patients (7.1%, 4/56) in the OPG group, without significant difference between the two groups (χ(2)=0.505, P=0.477). Conclusion: Laparoscopic proximal gastrectomy with double-tract reconstruction is safe and feasible without increasing the risk of postoperative complication and reflux esophagitis.


Subject(s)
Adenocarcinoma , Laparoscopy , Stomach Neoplasms , Adenocarcinoma/surgery , Adolescent , Adult , Aged , Aged, 80 and over , Esophagogastric Junction/surgery , Female , Gastrectomy , Humans , Male , Middle Aged , Retrospective Studies , Stomach Neoplasms/surgery , Treatment Outcome , Young Adult
3.
Eur Rev Med Pharmacol Sci ; 25(24): 7726-7733, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34982434

ABSTRACT

OBJECTIVE: Coal workers' pneumoconiosis (CWP) is a chronic inflammatory and fibrotic pulmonary disease that involves a complex interaction of multiple environmental and genetic factors. Polymorphism, as a genetic factor, may affect the onset of the disease in susceptible populations. The present study investigated the association between the polymorphisms of six genes and CWP risk in a Chinese Han population. PATIENTS AND METHODS: Six polymorphisms (CASP8 rs3834129, IL1A rs1800587, IL6 rs1800796, IL4 rs2070874, TNFA rs361525, and NLRP3 rs1539019) were examined in 222 CWP subjects and 247 dust-exposed control subjects. RESULTS: The CASP8 rs3834129 Ins/Del genotype significantly decreased CWP risk (p=0.040; adjusted odds ratio [OR] = 0.586; 95% confidence interval [CI] 0.367-0.935) compared with the Ins/Ins genotype. Stratification analyses revealed a significant interaction between the heterozygous Ins/Del genotype and age. Compared with the Ins/Ins + Del/Del genotype, this was particularly evident among subjects aged 41-60 (p<0.001; adjusted OR = 0.054; 95% CI 0.007-0.420) and those with an exposure time of 20-29 years (p=0.014; adjusted OR = 0.392; 95% CI 0.183-0.842). This decreased risk was also found in the group with former smokers (p=0.012; adjusted OR = 0.448; 95% CI 0.238-0.844). Findings revealed that the heterozygous Ins/Del genotype of CASP8 rs3834129 was related to a significantly decreased risk of stage I CWP (p=0.045; adjusted OR = 0.592; 95% CI 0.353-0.992), but not stage II or III CWP. CONCLUSIONS: Our study indicated that the heterozygous Ins/Del genotype of CASP8 rs3834129 significantly decreased CWP risk in a Chinese Han population.


Subject(s)
Anthracosis/genetics , Caspase 8/genetics , Aged , Aged, 80 and over , Anthracosis/epidemiology , Asian People/genetics , Case-Control Studies , China/epidemiology , Ethnicity/genetics , Genetic Predisposition to Disease , Genotype , Heterozygote , Humans , Male , Middle Aged , Odds Ratio , Polymorphism, Single Nucleotide
5.
Zhonghua Xue Ye Xue Za Zhi ; 38(2): 118-123, 2017 Feb 14.
Article in Chinese | MEDLINE | ID: mdl-28279035

ABSTRACT

Objective: To investigate the effect of minimal residual disease (MRD) monitoring by multiparameter flow cytometry (MFC) pre-conditioning on prognosis of acute myeloid leukemia in first complete remission (CR(1)-AML) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) , and to explore the value of MRD monitoring by MFC in the prognosis evaluation on allo-HSCT in CR(1)-AML. Methods: Between April 2012 and March 2015, consecutive 186 patients with CR(1)-AML who underwent allo-HSCT were analyzed retrospectively. MRD in BM before conditioning was detected by eight-color MFC. Any level of residual disease was considered to be MRD positive. Results: ①Of 186 patients, MRD was negative in 151 patients, positive in 35 patients (<1% in 25 patients and 1% to 3% in 10 patients) . ② With the median follow up of 18 (5-41) months, two-year DFS was 80.0% (95%CI 68.5%-92.3%) . Univariate analysis showed that MRD positive patients had lower DFS[62.9% (95%CI 50.6%-75.2%) vs 88.9% (95%CI 76.6%-100.0%) , P<0.001], higher relapse[11.4% (95%CI 4.1%-29.0%) vs 3.3% (95% CI 0.6%-20.9%) , P=0.003] and higher NRM [25.7% (95% CI 8.1%-43.3%) vs 7.9% (95% CI 1.3%-26.5%) , P=0.001] after HSCT compared with that of MRD negative patients. Secondary AML showed lower DFS than primary AML [60.0% (95% CI 42.4%-76.6%) vs 86.0% (95% CI 68.4%-100.0%) , P=0.004]. ③Multivariate analysis indicated that MRD positive pre-HSCT was the independent risk factor on DFS [HR=4.565 (95%CI 2.918-9.482) , P<0.001], relapse [HR=5.854 (95%CI 1.538-22.288) , P=0.010] and NRM [HR=3.379 (95%CI 1.361-8.391) , P=0.009] after allo-HSCT in CR(1)-AML. Conclusion: MRD positive pre-conditioning was the only negative impact factor for patients with CR(1)-AML after allo-HSCT. MRD by MFC can be used to assess the prognosis of CR(1)-AML after allo-HSCT.


Subject(s)
Neoplasm, Residual , Chronic Disease , Flow Cytometry , Hematopoietic Stem Cell Transplantation , Humans , Journal Impact Factor , Leukemia, Myeloid, Acute , Prognosis , Recurrence , Retrospective Studies , Risk Factors , Transplantation, Homologous
6.
Zhonghua Xue Ye Xue Za Zhi ; 38(1): 44-49, 2017 Jan 14.
Article in Chinese | MEDLINE | ID: mdl-28219225

ABSTRACT

Objective: To analyze the effect of NCCN (2015) risk stratification on prognosis of patients with acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) . Methods: Retrospective analysis of 258 patients with AML in CR (186 cases in CR(1), 72 cases in CR(2)) who underwent allogeneic HSCT in our hospital between April 2012 and March 2015 according to NCCN (2015) risk stratification. Of them, 63 cases were classified as low risk, 112 cases intermediate risk and 83 cases high risk. Results: ①With the median follow up of 18 (5-41) months, two-year disease free surviva (DFS) in 258 patients was 78.0% (95% CI 60.4%-96.6%) . Two-year DFS in AML after transplantation was 78.6% (95% CI 61.0%-96.2%) in low risk, 76.0% (95% CI 84.0%-93.6%) in intermediate risk and 80.3% (95% CI 62.7%-97.9%) (P=0.886) in high risk groups respectively. ②Univariate analysis showed that DFS has no significant difference in patient age, the median disease course before HSCT, the WBC number at the beginning of the disease, blood routine and chromosomes examination before transplantation, extramedullary disease before transplantation, disease status before transplantation, conditioning regimen, donor type, donor and recipient sex, recipient blood type, transfused MNC number, transfused CD34(+) cell number and transfused CD3(+) cell number. DFS was significant lower in primary AML than that in secondary AML (P=0.006) and also lower in MRD positive than that in MRD negative (P=0.003) . The accumulative relapse was significant higher in CR(2) compared to that in CR(1) (P=0.046) . Accumulative non-relapse mortality (NRM) was significanlyt higher in secondary AML compared to that in primary AML (P=0.004) and also higher in MRD positive compared to that in MRD negative (P=0.010) . ③Multivariate analysis showed that MRD positive was the only significant factor in DFS and NRM. Conclusion: Allo-HSCT treatment of AML CR patients could achieve a high efficacy, which is similar between CR(1) and CR(2) patients. There is no significant correlation between NCCN (2015) risk stratification and the prognosis of AML patients with allo-HSCT treatment. Pre-conditioning MRD status monitored by multiparameter flow cytometry was the only impact factor on DFS and NRM in allo-HSCT for CR-AML patients.


Subject(s)
Leukemia, Myeloid, Acute , Chronic Disease , Flow Cytometry , Hematopoietic Stem Cell Transplantation , Humans , Journal Impact Factor , Prognosis , Recurrence , Retrospective Studies , Risk , Tissue Donors , Transplantation, Homologous
7.
Pharmazie ; 72(7): 408-413, 2017 Jul 03.
Article in English | MEDLINE | ID: mdl-29441938

ABSTRACT

UBR5 is recently recognized as a key player in a large number of prevalent cancers. In this study, we sought to explore the connection of UBR5 expression with cell proliferation, apoptosis, as well as the regulation mechanism in colon cancer cell line. SiUBR5 or oeUBR5 were separately applied to interfere the expression of UBR5. Western blot, DNA gel electrophoresis and qPCR were performed to detect the expression of UBR5 at mRNA and protein level. Then MTT and flow cytometry were used to explore the proliferation and apoptosis in a colon cancer cell line in vitro. Finally, we explored the interaction and correlation of UBR5 and P21 in the colon cancer regulation. We found that UBR5 was highly expressed in colon cancer not only at mRNA level but also at protein level. Moreover, UBR5 can promote the growth of colon cancer cells, and inhibit apoptosis. The mechanism exploration proved that UBR5 can degrade P21 via ubiquitination. All these findings suggest that UBR5 may be involved in progression of colon cancer and could be a new therapeutic target for this disease.


Subject(s)
Apoptosis/genetics , Cell Proliferation/genetics , Colonic Neoplasms/genetics , Ubiquitin-Protein Ligases/genetics , Blotting, Western , Cell Line, Tumor , Colonic Neoplasms/pathology , Disease Progression , Flow Cytometry , Gene Expression Regulation, Neoplastic , Humans , Polymerase Chain Reaction , RNA, Messenger/genetics , Ubiquitination
8.
Braz J Med Biol Res ; 46(9): 758-64, 2013 Sep.
Article in English | MEDLINE | ID: mdl-24068191

ABSTRACT

To explore the effects of adipose tissue-derived stem cells (ADSCs) on the proliferation and invasion of pancreatic cancer cells in vitro and the possible mechanism involved, ADSCs were cocultured with pancreatic cancer cells, and a cell counting kit (CCK-8) was used to detect the proliferation of pancreatic cancer cells. ELISA was used to determine the concentration of stromal cell-derived factor-1 (SDF-1) in the supernatants. RT-PCR was performed to detect the expression of the chemokine receptor CXCR4 in pancreatic cancer cells and ADSCs. An in vitro invasion assay was used to measure invasion of pancreatic cancer cells. SDF-1 was detected in the supernatants of ADSCs, but not in pancreatic cancer cells. Higher CXCR4 mRNA levels were detected in the pancreatic cancer cell lines compared with ADSCs (109.3 ± 10.7 and 97.6 ± 7.6 vs 18.3 ± 1.7, respectively; P<0.01). In addition, conditioned medium from ADSCs promoted the proliferation and invasion of pancreatic cancer cells, and AMD3100, a CXCR4 antagonist, significantly downregulated these growth-promoting effects. We conclude that ADSCs can promote the proliferation and invasion of pancreatic cancer cells, which may involve the SDF-1/CXCR4 axis.


Subject(s)
Adipose Tissue/pathology , Cell Proliferation , Chemokine CXCL12/analysis , Pancreatic Neoplasms/pathology , Receptors, CXCR4/analysis , Stem Cells/physiology , Adipocytes/cytology , Cell Differentiation , Cell Line, Tumor , Coculture Techniques , Culture Media, Conditioned , Enzyme-Linked Immunosorbent Assay , Humans , Neoplasm Invasiveness/physiopathology , Pancreatic Neoplasms/metabolism , RNA, Messenger/metabolism , Real-Time Polymerase Chain Reaction , Receptors, CXCR4/genetics , Receptors, CXCR4/metabolism , Stem Cells/pathology
9.
Braz. j. med. biol. res ; 46(9): 758-764, 19/set. 2013. graf
Article in English | LILACS | ID: lil-686576

ABSTRACT

To explore the effects of adipose tissue-derived stem cells (ADSCs) on the proliferation and invasion of pancreatic cancer cells in vitro and the possible mechanism involved, ADSCs were cocultured with pancreatic cancer cells, and a cell counting kit (CCK-8) was used to detect the proliferation of pancreatic cancer cells. ELISA was used to determine the concentration of stromal cell-derived factor-1 (SDF-1) in the supernatants. RT-PCR was performed to detect the expression of the chemokine receptor CXCR4 in pancreatic cancer cells and ADSCs. An in vitro invasion assay was used to measure invasion of pancreatic cancer cells. SDF-1 was detected in the supernatants of ADSCs, but not in pancreatic cancer cells. Higher CXCR4 mRNA levels were detected in the pancreatic cancer cell lines compared with ADSCs (109.3±10.7 and 97.6±7.6 vs 18.3±1.7, respectively; P<0.01). In addition, conditioned medium from ADSCs promoted the proliferation and invasion of pancreatic cancer cells, and AMD3100, a CXCR4 antagonist, significantly downregulated these growth-promoting effects. We conclude that ADSCs can promote the proliferation and invasion of pancreatic cancer cells, which may involve the SDF-1/CXCR4 axis.


Subject(s)
Humans , Adipose Tissue/pathology , Cell Proliferation , /analysis , Pancreatic Neoplasms/pathology , /analysis , Stem Cells/physiology , Adipocytes/cytology , Cell Differentiation , Cell Line, Tumor , Coculture Techniques , Culture Media, Conditioned , Enzyme-Linked Immunosorbent Assay , Neoplasm Invasiveness/physiopathology , Pancreatic Neoplasms/metabolism , Real-Time Polymerase Chain Reaction , RNA, Messenger/metabolism , /genetics , /metabolism , Stem Cells/pathology
10.
Bone Marrow Transplant ; 36(4): 349-54, 2005 Aug.
Article in English | MEDLINE | ID: mdl-15968293

ABSTRACT

Haploidentical donors are available for most patients who need allografts but do not have matched donors. However, GVHD, rejection, delayed immune reconstitution, and infections have been significant barriers. We designed a haploidentical BMT protocol focusing on prevention of GVHD and rejection. A total of 53 leukemic patients underwent haploidentical G-CSF-primed BMT without ex vivo T-cell depletion. GVHD prophylaxis consisted of antithymocyte globulin, cyclosporine, methotrexate, and mycophenolate mofetil. In all, 38 patients (the CD25 group) received additional anti-CD25 monoclonal antibody basiliximab. The results were compared to 15 patients who did not receive basiliximab. All patients achieved trilineage engraftment with full-donor chimerism. The incidence of acute II-IV GVHD was 11% in the CD25 group vs 33% in the control group (P=0.046). The overall incidence of extensive chronic GVHD was 15%. T, B, and NK cells recovered within 12 months post transplant. The disease-free survival at 2 years was 53% with a median follow-up of 31 months. In conclusion, G-CSF primed haploidentical BMT along with sequential immunosuppressive agents as described here deserves further study.


Subject(s)
Antibodies, Monoclonal/administration & dosage , Bone Marrow Transplantation/adverse effects , Graft vs Host Disease/prevention & control , Haplotypes , Premedication , Recombinant Fusion Proteins/administration & dosage , Adolescent , Adult , Basiliximab , Bone Marrow Transplantation/immunology , Bone Marrow Transplantation/methods , Child , Drug Therapy, Combination , Female , Graft Survival , Graft vs Host Disease/drug therapy , Hematologic Neoplasms/complications , Hematologic Neoplasms/mortality , Hematologic Neoplasms/therapy , Humans , Immune System/cytology , Immunosuppressive Agents/administration & dosage , Incidence , Male , Receptors, Interleukin-2/immunology , Survival Analysis
11.
Dig Surg ; 20(2): 107-14, 2003.
Article in English | MEDLINE | ID: mdl-12686777

ABSTRACT

BACKGROUND/AIM: Cyclooxygenase-2 (COX-2) is one of the key isoenzymes in the production of prostaglandins, and is believed to be involved in carcinogenesis. This study was conducted to examine the role of COX-2 in the development and biological behavior of stomach cancer. METHODS: Expression of COX-2 at the mRNA and protein levels was analyzed using RT-PCR and immunoblotting assay in 50 cancerous and corresponding non-cancerous tissue specimens. Also, COX-2 expression was detected by an immunohistochemical method in 55 paraffin-embedded gastric adenocarcinoma tissues. RESULTS: Of the 50 carcinoma tissue samples analyzed, 38 (76.0%) had overexpression of COX-2 as compared to the paired non-cancerous specimens. The overexpression of COX-2 (91.7%) was more prevalent in tumors with sizes of >5 cm than those (61.5%) of 6 metastatic nodes compared to those with

Subject(s)
Adenocarcinoma/enzymology , Adenocarcinoma/pathology , Isoenzymes/metabolism , Prostaglandin-Endoperoxide Synthases/metabolism , Stomach Neoplasms/enzymology , Stomach Neoplasms/pathology , Adenocarcinoma/mortality , Adult , Aged , Base Sequence , Biomarkers, Tumor/analysis , Biopsy, Needle , Blotting, Western , Case-Control Studies , Culture Techniques , Cyclooxygenase 2 , Female , Humans , Immunohistochemistry , Isoenzymes/analysis , Male , Membrane Proteins , Middle Aged , Molecular Sequence Data , Neoplasm Staging , Probability , Prognosis , Prostaglandin-Endoperoxide Synthases/analysis , RNA, Messenger/analysis , Reference Values , Reverse Transcriptase Polymerase Chain Reaction/methods , Sensitivity and Specificity , Stomach Neoplasms/mortality
12.
Bone Marrow Transplant ; 30(12): 861-6, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12476277

ABSTRACT

Based on our encouraging results of G-CSF-primed HLA-matched related marrow transplants for high-risk leukemia, we extended the study from matched related to haploidentical transplants using G-CSF primed marrow and sequential immunosuppressants to prevent both graft-versus-host disease (GVHD) and host-versus-graft rejection (HVGR). Fifteen high-risk leukemia patients, who needed urgent transplantation but lacked an HLA-matched donor, underwent G-CSF-primed haploidentical marrow transplantation without ex vivo T cell depletion. Donors were given G-CSF (Lenograstim) at 3-4 microg/kg/day for 7 days prior to marrow harvest. GVHD and HVGR prophylaxis were combined in the sequential usage of cyclosporin A, methotrexate, anti-thymocyte globulin and mycophenolate mofetil. All patients established sustained trilineage engraftment at a median of 19 days and 21 days for neutrophil and platelets respectively. G-CSF priming significantly increased CD34(+) and CFU-GM cells, reduced total lymphocytes and reversed the CD4(+)/CD8(+) ratio in the donor marrow. The incidence of grade II-IV acute GVHD was 33.3%. Nine patients survived more than a year with a Karnofsky performance status of 100%. Estimated overall disease-free survival at 2 years was 60 +/- 7%. In conclusion, using G-CSF priming marrow grafts along with sequential immunosuppressants provided an excellent alternative for the treatment of high-risk hematological malignancy in patients who lack matched donors.


Subject(s)
Bone Marrow/drug effects , Granulocyte Colony-Stimulating Factor/pharmacology , Leukemia/therapy , Peripheral Blood Stem Cell Transplantation/methods , Recombinant Proteins/pharmacology , T-Lymphocytes , Adolescent , Adult , Antilymphocyte Serum/therapeutic use , Cell Lineage , Child , Cyclosporine/therapeutic use , Disease-Free Survival , Female , Graft Survival , Graft vs Host Disease/prevention & control , HLA Antigens/genetics , Haplotypes/genetics , Histocompatibility , Humans , Immunosuppressive Agents/therapeutic use , Lenograstim , Leukemia/epidemiology , Life Tables , Lymphocyte Depletion , Male , Methotrexate/therapeutic use , Middle Aged , Mycophenolic Acid/analogs & derivatives , Mycophenolic Acid/therapeutic use , Peripheral Blood Stem Cell Transplantation/statistics & numerical data , Recurrence , Risk Factors , Survival Analysis , Treatment Outcome
13.
Clin Transplant ; 15(5): 317-23, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11678957

ABSTRACT

Graft-versus-host disease (GVHD) and infection are major obstacles to successful allogeneic bone marrow transplantation (allo-BMT). In an attempt to improve the results of HLA-identical sibling BMT, we investigated the effect of accelerating hemopoietic reconstitution and reducing acute GVHD (aGVHD) in allo-BMT receiving G-CSF-stimulated donor marrow and the preliminary biological mechanism. The donors of 30 patients (study group) with leukemia were given G-CSF 3-4 microg/kg/d for 7 doses prior to marrow harvest. The results of subsequent engraftment in the recipients were compared with those of 18 patients without G-CSF (control group). Five donors themselves were studied to assess the effects of G-CSF on the hematopoietic progenitor cells and lymphocyte subsets in the bone marrow (BM). We observed that the stimulated BM yielded higher numbers of nucleated cells as well as CFU-GM and CD34+ cells (p<0.01), and that hemopoietic reconstitution was accelerated. The median number of days of granulocyte count exceeding 0.5x10(9)/L and platelet count exceeding 20x10(9)/L was 16 (range 10-23 d) and 18.5 (range 13-31 d), respectively (control group: median 22 d, range 13-29 d and median 23 d, range 17-34 d; p=0.001). The incidence of grade II-IV severe aGVHD was very low, with only 1 case (3.3%) with acute grade II aGVHD limited to the skin in the study group. Five of 18 patients in the control group manifested grade II-IV severe aGVHD (27.8%, p=0.02). The number of T-lymphocyte subsets in the harvested BM using G-CSF stimulation was changed. In the G-CSF-stimulated marrow group, CD4+ decreased and CD8+ increased significantly (p=0.02). The changes of progenitor cells and T-lymphocyte subsets in donors' BM from pre- and post-G-CSF stimulation showed that the percentage of CD4+ reduced (p=0.04) and that of CD8+ increased (p=0.06), while that of CD34+ also increased (p=0.002). The incidence of chronic GVHD and relapse had no significant difference between both groups. These results indicate that allo-BMT in BM G-CSF priming can accelerate engraftment and minimize the incidence of severe aGVHD. There is a trend in favor of improved transplantation-related mortality.


Subject(s)
Bone Marrow Transplantation/methods , Bone Marrow/drug effects , Graft vs Host Disease/prevention & control , Granulocyte Colony-Stimulating Factor/pharmacology , Hematopoietic Stem Cell Mobilization/methods , Adolescent , Adult , Case-Control Studies , Chi-Square Distribution , Child , Disease-Free Survival , Female , Flow Cytometry , Graft vs Host Disease/epidemiology , Humans , Incidence , Leukemia/therapy , Male , Middle Aged , Transplantation Conditioning , Transplantation, Homologous , Treatment Outcome
14.
J Nutr Biochem ; 12(2): 81-87, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11182550

ABSTRACT

The hormone-sensitive and lipoprotein lipases are critical determinants of the metabolic adaptation to starvation. Additionally, the uncoupling proteins have emerged with potential roles in the metabolic adaptations required by energy deficiency. The objective of this study was to evaluate the expression (mRNA abundance) of uncoupling proteins 2 and 3 and that of hormone-sensitive and lipoprotein lipase in the adipose tissue and skeletal muscle of the pig in relationship to feed deprivation. Thirty-two male castrates (87 kg +/- 5%) were assigned at random to fed and feed-deprived treatment groups. After 96 hr, the pigs were euthanized and adipose and skeletal muscle tissue obtained for total RNA extraction and nuclease protection assays. Feed deprivation increased uncoupling protein 3 mRNA abundance 103-237% (P < 0.01) in longissimus and red and white semitendinosus muscle. In contrast, the increase in uncoupling protein 3 mRNA in adipose tissue was only 23% (P < 0.06), and adipose uncoupling protein 2 mRNA was not influenced (P > 0.66) by feed deprivation. The increased abundance of uncoupling protein 2 mRNA in the longissimus muscle of feed-deprived pigs was small (22%), but significant (P < 0.04). The expression of hormone-sensitive lipase was increased 46% and 64% (P < 0.04) in adipose tissue and longissimus muscle, respectively, by feed deprivation, whereas adipose lipoprotein lipase expression was reduced (P < 0.01) to 20% of that of the fed group. Longissimus lipoprotein lipase expression in the feed-deprived group was 37% of that of the fed group (P < 0.01), and similar reductions were detected in red and white semitendinosus muscle. Overall, these findings indicate that uncoupling protein 3 expression in skeletal muscle is quite sensitive to starvation in the pig, whereas uncoupling protein 2 changes are minimal. Furthermore, we conclude that hormone-sensitive lipase is upregulated at the mRNA level with prolonged feed deprivation, whereas lipoprotein lipase is downregulated.

15.
J Interferon Cytokine Res ; 18(10): 879-88, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9809624

ABSTRACT

The objective of the present study was to evaluate the effect of the proinflammatory cytokines, tumor necrosis factor-alpha (TNF-alpha) and interleukin-1-alpha (IL-1a), on myoblast proliferation and fusion and on myocyte protein metabolism and stress protein expression. Proliferation was suppressed (p < 0.05) by both cytokines, alone and in combination, and at lower concentrations, the suppression was additive. Likewise, fusion was retarded (p < 0.05) by these cytokines alone and in combination. Myosin synthesis was not altered acutely or chronically by TNF-alpha alone or by the combination of this cytokine with IL-1alpha. Chronic exposure to TNF-alpha did not alter total cellular protein synthesis, but exposure to IL-1alpha and the cytokine combination resulted in an increase (14% to 19%, p < 0.05) in synthesis. Neither total cellular protein nor myosin degradation were influenced by either cytokine alone or by the combination. There was no detectable induction, acutely or chronically, of any of the stress proteins evaluated (HSC70, HSP70, or HSP60). These data suggest that cytokines may alter muscle growth and development prenatally and postnatally and that the changes in muscle protein metabolism during periods of immune challenge are not direct effects of TNF-alpha or IL-1alpha.


Subject(s)
Cell Fusion/drug effects , Heat-Shock Proteins/biosynthesis , Interleukin-1/pharmacology , Muscle Proteins/metabolism , Myogenic Regulatory Factors/pharmacology , Tumor Necrosis Factor-alpha/pharmacology , Cell Division/drug effects , Humans , Recombinant Proteins/pharmacology
16.
J Anim Sci ; 76(5): 1389-95, 1998 May.
Article in English | MEDLINE | ID: mdl-9621945

ABSTRACT

The objective of this study was to determine whether the improvements in growth and efficiency of gain achieved by recombinant porcine somatotropin (pST) are associated with altered expression of the p94, calpastatin, or alpha-actin genes in porcine longissimus (LD) muscle. Forty-eight barrows (initial 64.2 to 67.4 kg BW) were assigned to four treatments (n = 12) arranged as a 2 x 2 factorial in a randomized complete block design. Factors were duration of treatment (3 or 6 wk) and pST administration (0 or 3 mg x pig(-1) x d(-1)). Plasma samples were obtained 24 h after the first pST injection and at the end of the each treatment period for assays of selected variables. The LD samples were obtained at 3 and 6 wk of pST treatment. Northern blot analysis of calpastatin expression in LD muscle revealed three distinct transcription products of approximately 8.5 (CPST I), 5.5 (CPST II), and 2.5 (CPST III) kb; CPST II was reduced (P < .02) 33 and 61% by pST at 3 and 6 wk, respectively, whereas CPST I and III were not influenced (P > .12). Neither alpha-actin nor p94 was responsive to pST injection. As expected, pST resulted in higher (50%, P < .02) plasma insulin within 24 h and one- and twofold higher (P < .01) concentrations at 3 and 6 wk, respectively. Glucose was increased (P < .01) at 3 (15%) and 6 (10%) wk, whereas urea nitrogen was reduced (32 to 36%, P < .01). The efficacy of pST was evident in that ADG was improved (P < .01) 11 to 13% independent of time. Likewise, feed intake was reduced (P < .01) 10 to 11% and gain: feed improved (P < .01) approximately 26% for pigs receiving pST independent of time. These data indicate that the enhanced muscle growth achieved by pST is not associated with altered expression of p94 or alpha-actin, or an increase in the abundance of any calpastatin transcription product.


Subject(s)
Actins/genetics , Calcium-Binding Proteins/genetics , Calpain/genetics , Growth Hormone/pharmacology , RNA, Messenger/analysis , Swine/growth & development , Actins/drug effects , Animals , Blood Glucose/analysis , Blood Glucose/drug effects , Blood Urea Nitrogen , Blotting, Northern/veterinary , Calcium-Binding Proteins/drug effects , Calpain/drug effects , Gene Expression/drug effects , Insulin/blood , Male , RNA, Messenger/drug effects , Recombinant Proteins/pharmacology , Transcription, Genetic/drug effects , Weight Gain/drug effects
17.
Respir Med ; 88(1): 27-9, 1994 Jan.
Article in English | MEDLINE | ID: mdl-8029510

ABSTRACT

The measurement of CA50 in serum and pleural fluid by immunoradiometric assay was presented in 45 (27 malignancy and 18 tuberculosis) patients with pleural effusion. The mean CA50 level in malignant effusion (89.26 +/- 122.32 U ml-1) was significantly higher than that in tuberculous effusion (5.18 +/- 8.65 U ml-1) (P < 0.001). CA50 levels of pleural fluid above an arbitrary level of 20 U ml-1 were found in 78% of malignant fluids and in 6% of tuberculous fluids. The serum CA50 value from 27 patients with malignant effusion (58.67 +/- 85.85 U ml-1) was also higher than that from 18 patients with tuberculous effusion (6.18 +/- 8.37 U ml-1) (P < 0.001). CA50 levels of serum above the same level were found in 58% of patients with malignant fluid and in 6% of patients with tuberculous fluid. The results suggested that the measurement of CA50 in pleural effusion may be helpful in the differential diagnosis between tuberculous and malignant effusions.


Subject(s)
Adenocarcinoma/immunology , Antigens, Tumor-Associated, Carbohydrate/analysis , Carcinoma, Small Cell/immunology , Carcinoma, Squamous Cell/immunology , Lung Neoplasms/immunology , Pleural Effusion/immunology , Tuberculosis, Pulmonary/immunology , Adenocarcinoma/blood , Antigens, Tumor-Associated, Carbohydrate/blood , Breast Neoplasms/blood , Breast Neoplasms/chemistry , Carcinoma, Small Cell/blood , Carcinoma, Squamous Cell/blood , Humans , Immunoradiometric Assay , Lung Neoplasms/blood , Tuberculosis, Pulmonary/blood
18.
J Anim Sci ; 72(1): 62-7, 1994 Jan.
Article in English | MEDLINE | ID: mdl-7908017

ABSTRACT

To determine the temporal effect of ractopamine (Rac), a phenethanolamine, on adipose lipogenic enzyme activity and gene expression, 20 crossbred barrows were fed Rac (20 mg/kg of diet) for 0, 1, 8, or 24 d before slaughter (105 +/- 1 kg). Ractopamine had no effect (P > .05) on the activity of acetyl-coenzyme A carboxylase or malic enzyme in either the middle or outer layers of subcutaneous adipose tissue. Similarly, mRNA abundance for acetyl-coenzyme A carboxylase and the glucose transport proteins Glut 1 and Glut 4 were not affected by Rac in either adipose depot. Despite the inability of Rac to affect adipose tissue metabolism, Rac increased nitrogen retention, longissimus muscle area, and alpha-actin gene expression in skeletal muscle. Results indicate that Rac was not a functional beta-adrenergic agonist toward adipose tissue in this study. We suggest that the response to Rac in adipose tissue is masked by a combination of factors including tissue insensitivity, Rac-dose limitation, inherent partial agonism of Rac, and beta-adrenoceptor down-regulation.


Subject(s)
Adipose Tissue/drug effects , Muscle Proteins , Phenethylamines/pharmacology , Swine/metabolism , Acetyl-CoA Carboxylase/genetics , Acetyl-CoA Carboxylase/metabolism , Adipose Tissue/enzymology , Adipose Tissue/metabolism , Animals , Blotting, Northern , Down-Regulation , Gene Expression Regulation , Glucose Transporter Type 1 , Glucose Transporter Type 4 , Malate Dehydrogenase/genetics , Malate Dehydrogenase/metabolism , Male , Monosaccharide Transport Proteins/genetics , Monosaccharide Transport Proteins/metabolism , Muscles/drug effects , Muscles/metabolism , RNA, Messenger/biosynthesis , Swine/genetics
19.
J Anim Sci ; 72(1): 75-80, 1994 Jan.
Article in English | MEDLINE | ID: mdl-7908018

ABSTRACT

We have evaluated the effect of feeding ractopamine (Rac), a phenethanolamine lean enhancer being developed for commercial use in finishing pigs, on beta-adrenoceptor (beta-AR) number and ligand-receptor binding affinity in adipose and muscle tissues. Pigs weighing 78 +/- 1 kg were fed Rac (20 mg/kg of diet) for 0 (control), 1, 8, or 24 d before being killed at 105 +/- 1 kg BW. beta-adrenoceptor density (per milligram of protein) was decreased by Rac up to approximately 50% in both the middle and the outer layers of subcutaneous (SQ) adipose tissue. Orthogonal contrasts indicated significant (P < or = .05) linear effects of Rac in middle and outer SQ adipose tissue, and also a significant (P < or = .05) quadratic effect of Rac in the middle layer. Ractopamine did not affect the maximal binding (Bmax) of longissimus muscle. The relative affinity with which the beta-AR population of the tissues examined bound the radioligand ([3H]dihydroalprenolol) was not influenced by Rac. Likewise, feeding Rac had no effect on the affinity of the beta-AR for Rac. The data indicate that a Rac-induced reduction in the Bmax of adipose tissue may account for the diminished in vitro lipolytic potency of exogenous Rac after prolonged periods of Rac feeding, and that Rac-induced desensitization differs between adipose and skeletal muscle tissues.


Subject(s)
Adipose Tissue/drug effects , Adrenergic beta-Agonists/pharmacology , Muscles/drug effects , Phenethylamines/pharmacology , Swine/metabolism , Adipose Tissue/metabolism , Animals , Binding, Competitive , Down-Regulation , Growth Substances/pharmacology , Ligands , Male , Muscles/metabolism , Radioligand Assay , Random Allocation , Receptors, Adrenergic/analysis , Receptors, Adrenergic/drug effects , Receptors, Adrenergic/metabolism
20.
Biochimie ; 75(10): 931-6, 1993.
Article in English | MEDLINE | ID: mdl-8312396

ABSTRACT

Calpains are non-lysosomal proteases involved in myofibrillar protein degradation. To facilitate studying the expression of the porcine calpain genes and their influence on protein accretion, we have cloned partial cDNAs for mu- and m-calpain from porcine skeletal muscle via PCR amplification. A 289 bp fragment for mu-calpain and a 629 bp fragment for m-calpain were cloned into the EcoRV site of pBluescript II KS+ vector. The nucleotide sequence for porcine mu-calpain and m-calpain were 92% and 90% identical to corresponding regions of rabbit mu- and m-calpain, respectively. The deduced amino acid sequences for both mu- and m-calpain share 94% identity with respective rabbit mu- and m-calpains. Isoform specificity was validated by Southern hybridization of mu- and m-calpain probes with cloned mu- and m-calpain fragments and Northern hybridization with pig muscle mRNA. These clones will be used to evaluate the role of calpain expression in muscle hypertrophy.


Subject(s)
Calpain/genetics , Muscles/chemistry , Amino Acid Sequence , Animals , Base Sequence , Blotting, Northern , Blotting, Southern , Calpain/chemistry , Cloning, Molecular , DNA, Complementary/chemistry , Gene Expression , Molecular Sequence Data , Nucleic Acid Hybridization , Polymerase Chain Reaction , Rabbits , Sequence Alignment , Swine
SELECTION OF CITATIONS
SEARCH DETAIL
...